Drugs / ICV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05330871 Comparator | Apr → Jun 2022 | COVID-19 | Seventh Medical Center of PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICV | “ICV, 1 dose 0.5ml” NCT05330871 ↗ |
| Modality | Vaccine | “Inactivated COVID-19 Vaccine” NCT05330871 ↗ |
| Route | Intramuscular | “0.5ml intramuscular inactivated vaccine ICV” NCT05330871 ↗ |